Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
Pseudomonas aeruginosa
amikacin
aztreonam
ceftazidime-avibactam
colistin
combination therapy
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
03 09 2021
03 09 2021
Historique:
pubmed:
29
7
2021
medline:
18
1
2022
entrez:
28
7
2021
Statut:
ppublish
Résumé
Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from
Identifiants
pubmed: 34319141
doi: 10.1128/Spectrum.00585-21
pmc: PMC8552783
doi:
Substances chimiques
Anti-Bacterial Agents
0
Azabicyclo Compounds
0
Drug Combinations
0
avibactam, ceftazidime drug combination
0
Ceftazidime
9M416Z9QNR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0058521Références
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29760124
Antimicrob Agents Chemother. 2011 Jul;55(7):3284-94
pubmed: 21555763
J Glob Antimicrob Resist. 2020 Sep;22:18-27
pubmed: 31863899
Antimicrob Agents Chemother. 2009 Aug;53(8):3430-6
pubmed: 19433570
BMC Infect Dis. 2013 Aug 19;13:380
pubmed: 23957376
PLoS Comput Biol. 2011 Jan 06;7(1):e1001043
pubmed: 21253559
J Antimicrob Chemother. 2012 Jun;67(6):1354-8
pubmed: 22441578
Drug Resist Updat. 2015 Jul-Aug;21-22:41-59
pubmed: 26304792
J Glob Antimicrob Resist. 2019 Sep;18:37-44
pubmed: 31154007
CPT Pharmacometrics Syst Pharmacol. 2017 Mar;6(3):197-207
pubmed: 28145085
Antimicrob Agents Chemother. 2015 Oct;59(10):6605-7
pubmed: 26195508
Drug Resist Updat. 2011 Feb;14(1):1-21
pubmed: 21288762
Int J Antimicrob Agents. 2016 Dec;48(6):725-727
pubmed: 28128096
Int J Infect Dis. 2017 Dec;65:1-3
pubmed: 28951106
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28461318
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28827415
Infect Dis (Lond). 2020 Sep;52(9):616-624
pubmed: 32427010
Infection. 2009 Oct;37(5):461-5
pubmed: 19499183
Antimicrob Agents Chemother. 2015 Nov 16;60(2):752-6
pubmed: 26574008
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29530842
Clin Ther. 2001 Aug;23(8):1231-44
pubmed: 11558860
Int J Antimicrob Agents. 2019 May;53(5):612-619
pubmed: 30682497
Eur Rev Med Pharmacol Sci. 2013 Feb;17(3):285-91
pubmed: 23426530
J Antimicrob Chemother. 2018 Mar 1;73(3):658-663
pubmed: 29149337
Antimicrob Agents Chemother. 2003 Mar;47(3):905-9
pubmed: 12604520
Int J Antimicrob Agents. 2019 Aug;54(2):255-260
pubmed: 31071465
Ann Lab Med. 2017 Mar;37(2):174-176
pubmed: 28029009
Eur J Clin Pharmacol. 2020 Mar;76(3):349-361
pubmed: 31836928
Curr Infect Dis Rep. 2020 Jan 13;22(1):1
pubmed: 31933158
Infect Dis (Lond). 2017 Jul;49(7):521-527
pubmed: 28264618
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28993338
Antimicrob Agents Chemother. 2010 Jun;54(6):2646-54
pubmed: 20368395
Antimicrob Agents Chemother. 2015 May;59(5):2515-24
pubmed: 25691628
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115227
pubmed: 33086177
Intensive Care Med. 2014 Jul;40(7):998-1005
pubmed: 24687298
Antimicrob Agents Chemother. 2015 Feb;59(2):1020-9
pubmed: 25451057
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 32041712
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28223379
Antimicrob Agents Chemother. 2013 Oct;57(10):5104-11
pubmed: 23917322
J Antimicrob Chemother. 2018 Feb 1;73(2):456-461
pubmed: 29149302
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28167541
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28874376
Antimicrob Agents Chemother. 2019 Jul 25;63(8):
pubmed: 31182535